Viewing Study NCT01422304


Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2025-12-25 @ 7:06 PM
Study NCT ID: NCT01422304
Status: COMPLETED
Last Update Posted: 2021-02-12
First Post: 2011-08-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-10-12
Start Date Type: ACTUAL
Primary Completion Date: 2012-09-26
Primary Completion Date Type: ACTUAL
Completion Date: 2012-09-26
Completion Date Type: ACTUAL
First Submit Date: 2011-08-22
First Submit QC Date: None
Study First Post Date: 2011-08-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-08-19
Results First Submit QC Date: None
Results First Post Date: 2013-10-30
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-01-20
Last Update Post Date: 2021-02-12
Last Update Post Date Type: ACTUAL